ORIGINAL RESEARCH
Published on 27 Jul 2026
Identification of LILRB4 as a regulator of M2c macrophages and a potential immunotherapeutic target in ovarian cancer
doi 10.3389/fimmu.2026.1866073
- 475 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Reprogramming the Tumor Microenvironment and Translational Challenges of Immunotherapy in Gynecologic Cancers
Reprogramming the Tumor Microenvironment and Translational Challenges of Immunotherapy in Gynecologic Cancers
4,782
Total downloads
28k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 15 Jun 2026
Autophagy modulation in gynaecologic oncology: insights into immune regulation and therapeutic potential
doi 10.3389/fimmu.2026.1737681
- 1,035 views
REVIEW
Published on 15 May 2026
The enigmatic role of tumor dormancy cells in gynecologic cancers
doi 10.3389/fimmu.2026.1836770
- 1,706 views
REVIEW
Published on 07 May 2026
Artificial intelligence in ovarian cancer: advancing in precision diagnosis and clinical management
doi 10.3389/fimmu.2026.1795144
- 2,250 views
SYSTEMATIC REVIEW
Published on 23 Apr 2026
Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015–2024
doi 10.3389/fonc.2026.1732209
- 988 views
CASE REPORT
Published on 21 Apr 2026
Immune checkpoint inhibition in undifferentiated cervical sarcoma with early pelvic recurrence: a case report
doi 10.3389/fonc.2026.1783604
- 926 views
ORIGINAL RESEARCH
Published on 14 Apr 2026
STAT1 and IL-7 as potential diagnostic biomarkers for distinguishing high-grade from low-grade serous ovarian cancer: a multi-cohort analysis
doi 10.3389/fimmu.2026.1779912
- 1,083 views
- 1 citation
REVIEW
Published on 07 Apr 2026
Precision oncology in gynecologic cancers: molecular taxonomy, biomarker-guided therapeutics, and the challenge of therapeutic resistance
doi 10.3389/fonc.2026.1785469
- 2,705 views
- 1 citation
ORIGINAL RESEARCH
Published on 25 Mar 2026
PIK3CA mutation–induced immune microenvironment remodeling sensitizes cervical cancer to immunotherapy
doi 10.3389/fimmu.2026.1780752
- 1,817 views
CASE REPORT
Published on 13 Mar 2026
Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report
doi 10.3389/fonc.2026.1736364
- 1,482 views
- 1 citation
REVIEW
Published on 12 Mar 2026
Engineering immune-competent niches: strategies, applications, and translational hurdles in ovarian cancer organoid models
doi 10.3389/fimmu.2026.1773734
- 1,609 views
- 1 citation
CASE REPORT
Published on 13 Feb 2026
Leptomeningeal metastasis from large-cell neuroendocrine carcinoma of the cervix: a case report and literature review
doi 10.3389/fonc.2026.1734305
- 1,105 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.4 impact factor
- 6.6 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: